Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

NCT05695417 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
21
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ocular Therapeutix, Inc.